Clinical Trials in the Category "Carcinoma, Squamous Cell"
Drug Intervention Trials that are Recruiting
Study Title |
Principal Investigator | Disease Category | |
 |
|||
| BIBW 2992 in Head&Neck Cancer |
Dr. A. Dimitrios Colevas |
Head and Neck Cancer
Carcinoma, Squamous Cell | |
|
|||
| Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer |
Amreen Husain |
Uterine Neoplasms
Uterine Cervical Neoplasms Adenocarcinoma Carcinoma, Squamous Cell | |
|
|||
| Phase II Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy |
Quynh-Thu Le |
Head and Neck Cancer
Carcinoma, Squamous Cell | |
|
|||
Trials not Recruiting
| Study Title |
Principal Investigator | Disease Category | |
|
|||
|
Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck
(Completed) |
Dr. A. Dimitrios Colevas |
Head and Neck Cancer
Carcinoma, Squamous Cell | |
|
|||
|
A Phase 2 Clinical Trial of the Effectiveness of IRX-2 in Treating Patients With Operable Head and Neck Cancer
(No longer recruiting) |
Dr Michael Kaplan |
Head and Neck Cancer
Carcinoma, Squamous Cell | |
|
|||
|
Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer
(No longer recruiting) |
Daniel T Chang |
Esophageal Neoplasms
Adenocarcinoma Carcinoma, Squamous Cell | |
|
|||
|
Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck
(Completed) |
Quynh-Thu Le |
Head and Neck Cancer
Carcinoma, Squamous Cell | |
|
|||
|
Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation
(No longer recruiting) |
Quynh-Thu Le Dr. Billy W. Loo Jr. M.D. Ph.D. |
Head and Neck Cancer
Carcinoma, Squamous Cell | |
|
|||
| The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials. Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials. |
Trial Administration